Deficient DNA repair capacity: A predisposing factor and high risk predictive marker in familial colorectal cancer

Journal of Experimental and Clinical Cancer Research

Volumn 18, Issue 1, 1999, Pages 33-37

  Ankathil, R ^a   Jyothish, B ^a   Madhavan, J ^a   Nair, M K ^a  

^a REGIONAL CANCER CENTRE   (India)

Author keywords

DNA repair; Familial colorectal cancer; Mutagen sensitivity

Indexed keywords

BLEOMYCIN; DNA;

ADULT; ARTICLE; CANCER RISK; CHROMOSOME ABERRATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA REPAIR; FAMILIAL CANCER; FEMALE; GENETIC SUSCEPTIBILITY; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

ADULT; BLEOMYCIN; CELLS, CULTURED; CHROMATIDS; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; DNA REPAIR; FAMILY; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LYMPHOCYTES; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT;

EID: 0032922816     PISSN: 03929078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Nair M.K.: Regional Cancer Centre, Annual Report 1995-96.
2. Hsu T.C.: Genetic susceptibility to Carcinogenesis. Cancer Bull., 38: 125-128, 1986.
3. Hsu T.C., Johnston D.A., Cherry L.M., Ramikissoon D., Schantz S.P., Jessup J.M., Winn R.J., Shirley L., Furlong C.: Sensitivity to genotoxic effects of bleomycin in humans. Possible relationship to environmental carcinogenesis. Int. J. Cancer, 43: 403-409, 1989.
4. Pathak S., Hopwood V.L., Hughes J.I. and Jackson G.L.: Identification of colon cancer predisposed individuals - A cytogenetic analysis. Amer. J. Gastroenterol., 86: 676-684, 1991.
5. Hsu T.C., Spitz M.R., Schantz S.P.: Mutagen sensitivity - a biological marker for cancer susceptibility. Cancer Epidemiol. Biomark. Prev., 1: 83-89, 1991.
6. Moorhead P.S., Nowell P.C., Mellmann W.J., Battipps D.W., Hungerford D.A.: Chromosome preparations of leukocytes cultured from human peripheral blood. Exp. Cell. Res., 20: 613-616, 1960.
7. Seabright M.: A rapid banding technique for human chromosomes. Lancet, ii: 971-972, 1971.
8. ISCN: Guidelines for cancer cytogentics: supplement to An International System for Human Cytogenetic Nomenclature. F. Mitelman (ed.). S. Karger, Basel (1991).
9. Spitz M.R., Fueger J.J., Beddingfield N.A., Annergers J.F., Hsu T.C., Newall G.R.: Chromosome sensitivity to bleomycin induced mutagenesis - an independent risk factor for upper aerodigestive tract cancers. Cancer Res., 49: 4626-4628, 1989.
10. Johnson M.R., Ramsay N., Cervanka J. and Wang N.: Retinoblastoma and its association with a deletion in chromosome 13. A survey using high resolution chromosome techniques. Cancer Genet. Cytogenet., 6: 29-37, 1982.
11. Orkin S.H., Goldman D.S., Sallan S.E.: Development of homozygosity for chromosome tip markers in wilm's tumour. Nature, 309: 172-174, 1984.
12. Bolger G.B., Stamberg J., Kirsch I.R., Hollis G.F., Schwartz-Thomas G.H.: Chromosome translocation t (14;22) and oncogenic variant in a pedigree with familial meningioma. New Engl. J. Med., 312: 564-567, 1985.
13. Hsu T.C., Cherry L.M., Samaan N.A.: Differential mutagen sensitivity in cultured lymphocytes of normal individuals and cancer patients. Cancer Genet. Cytogenet., 17: 307-313, 1985.
14. Schantz S.P., Spitz M.R., Hsu T.C.: Mutagen sensitivity in head and neck cancer patients: a biologic marker for risk of multiple primary malignancies. J. Nat. Cancer Inst., 82: 1773-1775, 1990.
15. Cloos J., Braakhuis B.J., Steen I., Cooper M.P., de Vries N., Nauta J.J., Snow G.B.: Increased mutagen sensitivity in head and neck squamous cell carcinoma patient, particularly those with multiple primary tumours. Int. J. Cancer, 56: 816-819, 1994.
16. Ankathil R., Bhattathiri V.N., Francis V.J., Ratheesan K., Jyothish B., Chandini R., Roy D., Elizabeth A.K., Nair M.K.: Mutagen sensitivity as a predisposing factor in familial oral cancer. Int. J. Cancer Prcd. Oncol., 69: 265-267, 1997.
17. Bondy M.L., Spitz M.R., Halabi S., Fueger J.J., Schantz S.P., Sample D., Hsu T.C.: Association between family history of cancer and mutagen sensitivity in upper aerodigestive tract cancer patients. Cancer Epidemiol. Bomarkers Prev., 2: 103-106, 1993.
18. Paterson M.C., Smith P.J.: Ataxia telangiectasia - an inherited human disorder involving hypersensitivity in ionizing radiation and related DNA damaging chemicals. Ann. Rev. Genet., 13: 291-318, 1979.
19. Harnden D.G.: Inherited factors in leukaemia and lymphoma. Cancer Res., 9: 705-707, 1985.